European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Tenders

Blood products tenders in Spain

Blood products tenders in Spain: 387 listed on GranTender since 2024; 2 open now. The median awarded contract value is about €16,000 (483 contracts with a stated value). Buyers with the most tenders: Comisión Delegada del Patronato de la Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (79), Gerencia de Atención Primaria del Area de Salud de Tenerife (32) and Servicio Andaluz de Salud (27); suppliers with the most contract awards: Instituto Grifols, S.A. (44), CSL Behring, S.A. (32) and BAXTER, S.L. (29). Sources: PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED. In 2025 the median contract value was €3,900; 65% of contracts drew a single bid (1.7 bids on average). Data as of 17 November 2026; updated daily.

Tenders
387
Open tenders
2
Awards
564
Awarded value awarded
€253,374,021
Awarded value contract
€245,467,065
Awarded value framework ceiling
€14,017,121
Median contract value awarded
≈ €16,000
Median contract value contract
≈ €150,000
Median contract value framework ceiling
≈ €370,000
Average bids per contract
1.4
Tenders in 2025
162 +78% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
Acuerdo marco para la contratación de inmunoglobulinas humanas inespecíficas para las gerencias del Servicio Cántabro de SaludServicio Cántabro de Salud€22,405,572Open12 November 2026
Suministro 400 ml inmunoglobulina antirrábicaÓrgano de Contratación de la Ciudad Autónoma de Ceuta€55,778Open9 November 2026
Suministro de Amiodarona, Aflibercept, Inmunoglobulina contra timocitos, Milrinona, medicamentos de distribución exclusiva de la firma “Sanofi Aventis, S.A." con destino al Servicio de Farmacia del Hospital Universitario 12 de OctubreServicio Madrileño de Salud - Hospital Universitario 12 de Octubre€1,397,031Awarded22 October 2026
El objeto del contrato es el suministro, instalación y puesta en funcionamiento de un sistema de infusión rápida de fluidos con calentamiento integrado destinado a la administración segura y controlada de soluciones intravenosas y hemoderivados en situaciones clínicas que requieren alta velocidad de infusión.Consorcio Hospital General Universitario de Valencia€38,348Awarded16 October 2026
inmunoglobulinasConsorcio Corporació Sanitària Parc Taulí de Sabadell€6,392,340Closed12 October 2026
Suministro de un sistema de autotransfusión perioperatoria destinado al bloque quirúrgico, para la realización de autotransfusión a los pacientes que rechazan hemoderivadosDepartamento de Salud Alcoy. Dirección Económica-Gerencia€36,400Closed28 September 2026
Suministro de medicamentos hemoderivadosServicio Murciano de Salud - Gerencia€6,265,600Closed24 September 2026
Contrato Basado para el Suministro de productos hemoderivados de uso terapéutico procedente del fraccionamiento industrial de plasma humano proveniente del Sistema Nacional de Salud para el Servicio Extremeño de Salud en ejecución del Acuerdo Marco 2024/049 de INGESADirección General de Planificación Económica€7,112,077Awarded18 September 2026
1er Contrato basado en el Acuerdo Marco Estatal para el suministro de vacunas de calendario y otras (AME202507ACM001) Lote 24Departamento de Salud Alcoy. Dirección Económica-Gerencia€32,186,000Awarded8 September 2026
Contratación del suministro de NIRSEVIMAB (anticuerpo monoclonal frente a enfermedad producida por virus respiratorio sincitial) destinado a la inmunización de neonatos y lactantes en Castilla-La Mancha para la temporada 2026-2027, basada en el Lote 24 del Acuerdo Marco estatal 202507ACM001, para la selección de suministradores de vacunas de calendario y otras y otros productos inmunizantes.Secretaría General de la Consejería de Educación, Cultura y Deportes de la Junta de Comunidades de Castilla-La Mancha€3,762,000Awarded2 September 2026
Suministro de solución anticoagulante ACD-A y de diversas presentaciones de solución fisiológica 0.9% para el Centro de Transfusión de la Comunitat Valenciana.Dirección del Centro de Transfusión de la Comunitat Valenciana€242,985Awarded25 August 2026
Suministro de fibra ósea desmineralizadaFundació Banc de Sang i Teixits de les Illes Balears€97,363Awarded10 August 2026
Suministro de Inmunoglobulina Antirrábica Humana Hyperrab.Consejería de Hacienda de la Ciudad Autónoma de Melilla€194,250Awarded31 July 2026
Adquisición de nirsevimab (anticuerpo monoclonal frente a enfermedad producida por virus respiratorio sincitial) destinado a la inmunización de neonatos y lactantes en castilla-la mancha para la temporada 2026-2027Secretaría General de la Consejería de Educación, Cultura y Deportes de la Junta de Comunidades de Castilla-La Mancha€3,762,000Closed30 July 2026
4ª PRO 6º CBAM INSTITUTO GRIFOLS, SAAcuerdo Marco con una única empresa por el que se fijan las condiciones para el suministro de hemoderivados de uso terapéutico elaborados a partir del fraccionamiento industrial del plasma humano procedente de los Centros de transfusión, tejidos y células pertenecientes a la Red Andaluza de Medicina Transfusional, Tejidos y Células del Servicio Andaluz de Salud. AM 2308/2021Servicio Andaluz de Salud€879,959Awarded14 July 2026
P.A. 2026-0-7 Inmunoglobulina humana solución para perfusiónDirección Gerencia de Atención Primaria de Toledo€6,604,500Awarded3 July 2026
SUMINISTRO DE MEDICAMENTOS INMUNOGLOBULINA G, AMIDOTRIZOATO, MACROGOL 3350 Y CLORHEXIDINA DIGLUCONATOServicio Madrileno de Salud, Hospital Universitario La Paz—Closed30 June 2026
Acuerdo marco para el suministro de varios medicamentos con destino a los servicios de farmacia de los centros dependientes del Servicio Navarro de Salud-Osasunbidea (FARM F134 - 2026). Los medicamentos son - Axitinib 1 mg - Azacitidina 25 mg/mL, vial - Dalbavancina 500 mg, vial - Paclitaxel albúmina 5 mg/mL, vial - Pemetrexed 25 mg/mL, vialServicio Navarro de Salud-Osasunbidea€1,918,061Closed25 June 2026
0000319/2025 suministro inmunoglobulina humana para los centros integrantes de la central provincial de compras de almería. por precios unitarios al amparo del art. 16.3.a) de la ley 9/2017, de 8 de noviembre. de contratos del sector público,procedimiento abierto y presentación electrónica de ofertasServicio Andaluz de Salud€14,082,431Awarded20 June 2026
Suministro Equipos de AféresisServicio Cántabro de Salud€789,210Awarded18 June 2026

Competition and prices

In 2025, half of the contracts were worth between €690 and €65,000, with a median of €3,900 (161 contracts with a stated awarded value). Contracts drew 1.7 bids on average (median 1) and 65% drew a single bid — based on 52 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 83% and the share of single-bid contracts fell from 90% to 65%. The usual procedures: direct award (49%), open procedure (30%), negotiation without a call for competition (9%) — of 345 tenders with a stated procedure.

The most contracts went to Instituto Grifols, S.A. (44), CSL Behring, S.A. (32) and BAXTER, S.L. (29) — together 19% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024134€23,000€2,700 – €240,0001.190% (77)
2025169€3,900€690 – €65,0001.765% (52)
2026 (so far)158€21,000€2,700 – €270,0001.756% (82)
All years563€16,000€1,900 – €170,0001.473% (252)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 61% of the 140 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 140 of the 172 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 4 companies won their first contract in our records here — 2% of the 181 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33141500 Haematological consumables
  • 33651500 Immune sera and immunoglobulins

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Blood products and immunoglobulins in neighbouring countries

Today, 2 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

ExpectedBuyerWhatWhy we expect itConfidence
now – Feb 2027
contract ends
Hospital Universitario Principe de AsturiasBlood products and immunoglobulins
Hyqvia vial 20 g (100 mg/ml) 200 ml, Hyqvia vial 30 g (100 mg/ml) 300 ml e Hyqvia vial 5 g (100 mg/ml) 50 ml
Typical value: ≈ €83,000
The current contract with TAKEDA FARMACEUTICA ESPAÑA, S.A. ends on 13 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2026
high
now – Feb 2027
contract ends
Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)Blood products and immunoglobulins
Suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial del plasma humano proveniente del Sistema Nacional de Salud
Typical value: ≈ €8.1m
The current contract with INSTITUTO GRIFOLS, S.A. ends on 5 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 09/2024
medium
now – Jan 2027
contract ends
Hospital Universitario La PazBlood products and immunoglobulins
Suministro de medicamentos exclusivos: Inmunoglobulina Anti Timocítica Conejo (TIMOGLOBULINA IMTIX), Milrinona (COROTROPE)
Typical value: ≈ €170,000
The current contract with SANOFI AVENTIS, S.A. ends on 20 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 05/2026
high
now – Jan 2027
contract ends
Dirección General de la Mutual Midat Cyclops, Mutua Colaboradora con la Seguridad Social, nº 1Blood products and immunoglobulins
Suministro de tejido músculo esquelético para Clínica MC Madrid
Typical value: ≈ €37,000
The current contract with BANC DE SANG I TEIXITS ends on 10 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 02/2025
medium
now – Feb 2027
contract ends
Gerencia de la Fundación Marqués de ValdecillaBlood products and immunoglobulins
Contrato basado en el acuerdo marco del INGESA ((2024/049) para el suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial de plasma humano proveniente del sistema nacional de salud, con destino al Banco de Sangre y Tejidos de Cantabria / Fundación Marqués de Valdecilla. Fraccionamiento plasma FMV/BSTC/CB 01/2025.
Typical value: ≈ €1.3m
The current contract with INSTITUTO GRIFOLS, S.A. ends on 16 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2025
high

Forecast from public data, not an announcement. Methodology.

Market reports

Blood products and immunoglobulins by city

Blood products and immunoglobulins in other countries

Blood products and immunoglobulins across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which blood products tenders in Spain are open now?
2 of the 387 blood products tenders in Spain listed on GranTender are open for bids. For example: Acuerdo marco para la contratación de inmunoglobulinas humanas inespecíficas para las gerencias del Servicio…; Suministro 400 ml inmunoglobulina antirrábica.
Where can I find blood products tenders in Spain?
GranTender lists them in one place, from PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED, with their buyers, winners and contract values; 2 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most blood products tenders in Spain?
By number of contracts won: Instituto Grifols, S.A. (44), CSL Behring, S.A. (32), BAXTER, S.L. (29).
Which buyers publish the most blood products tenders in Spain?
By number of tenders: Comisión Delegada del Patronato de la Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (79), Gerencia de Atención Primaria del Area de Salud de Tenerife (32), Servicio Andaluz de Salud (27).
Which CPV codes belong to “Blood products and immunoglobulins”?
33141500 Haematological consumables; 33651500 Immune sera and immunoglobulins; plus tenders without a usable CPV code whose title names the topic.
How many bids do blood products tenders in Spain receive on average?
In 2025, contracts drew 1.7 bids on average (median 1) and 65% drew a single bid — based on 52 contracts with a known number of bids.
How much are contracts for blood products tenders in Spain worth?
In 2025, half of the contracts were worth between €690 and €65,000, with a median of €3,900 (161 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 83% and the share of single-bid contracts fell from 90% to 65%.
Which procedures are used for blood products tenders in Spain?
The usual procedures: direct award (49%), open procedure (30%), negotiation without a call for competition (9%) — of 345 tenders with a stated procedure.
Which buyers get few offers in blood products tenders in Spain?
Since 1 November 2024, these buyers usually received one or two offers per contract: OSAKIDETZA - Servicio Vasco de Salud -Director General (median 1 bid over 19 contracts), Servicio Andaluz de Salud (median 1 bid over 21 contracts) and Gerencia de Atención Primaria del Area de Salud de Tenerife (median 1 bid over 13 contracts). Since 1 November 2024, 61% of the 140 contracts with a known number of bids had a single bid; the median was 1 bid.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.